Growth Metrics

Mirum Pharmaceuticals (MIRM) Times Interest Earned (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Times Interest Earned data on record, last reported at -$1.27 in Q4 2025.

  • For Q4 2025, Times Interest Earned rose 81.24% year-over-year to -$1.27; the TTM value through Dec 2025 reached -$1.54, up 74.87%, while the annual FY2025 figure was -$1.54, 74.87% up from the prior year.
  • Times Interest Earned reached -$1.27 in Q4 2025 per MIRM's latest filing, down from $0.72 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $0.72 in Q3 2025 and bottomed at -$14.08 in Q1 2021.
  • Average Times Interest Earned over 5 years is -$6.71, with a median of -$7.22 recorded in 2023.
  • Peak YoY movement for Times Interest Earned: decreased 16.7% in 2023, then skyrocketed 120.41% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at -$12.1 in 2021, then surged by 35.24% to -$7.84 in 2022, then decreased by 16.7% to -$9.15 in 2023, then grew by 26.0% to -$6.77 in 2024, then soared by 81.24% to -$1.27 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$1.27 in Q4 2025, $0.72 in Q3 2025, and -$1.39 in Q2 2025.